{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:52:46Z","timestamp":1781560366148,"version":"3.54.5"},"reference-count":3,"publisher":"American College of Physicians","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.7326\/annals-26-01793-jc","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:00:25Z","timestamp":1780347625000},"page":"JC64","source":"Crossref","is-referenced-by-count":0,"title":["In adults with acute VTE, apixaban vs. rivaroxaban reduced clinically relevant bleeding at 3 mo"],"prefix":"10.7326","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2565-5217","authenticated-orcid":false,"given":"Siraj","family":"Mithoowani","sequence":"first","affiliation":[{"name":"McMaster University, Hamilton, Ontario, Canada (S.M., W.L.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2508-1786","authenticated-orcid":false,"given":"Wendy","family":"Lim","sequence":"additional","affiliation":[{"name":"McMaster University, Hamilton, Ontario, Canada (S.M., W.L.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ACP Journal Club Editorial Team at McMaster University","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4285","reference":[{"key":"ANNALS-26-01793-R1","doi-asserted-by":"crossref","unstructured":"Fredman D, McNeil R, Eldar O, et al.\n                      Efficacy and safety of rivaroxaban versus apixaban for venous thromboembolism: a systematic review and meta-analysis of observational studies. J Thromb Thrombolysis. 2024;57:453-465. [PMID: 38127261]","DOI":"10.1007\/s11239-023-02926-3"},{"key":"ANNALS-26-01793-R2","doi-asserted-by":"crossref","unstructured":"Agnelli G, Buller HR, Cohen A, et al; AMPLIFY Investigators.\n                      Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med. 2013;369:799-808. [PMID: 23808982]","DOI":"10.1056\/NEJMoa1302507"},{"key":"ANNALS-26-01793-R3","doi-asserted-by":"crossref","unstructured":"EINSTEIN Investigators; Bauersachs R, Berkowitz SD, Brenner B, et al.\n                      Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499-2510. [PMID: 21128814]","DOI":"10.1056\/NEJMoa1007903"}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/ANNALS-26-01793-JC","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/ANNALS-26-01793-JC","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:03:08Z","timestamp":1781557388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ANNALS-26-01793-JC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":3,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.7326\/ANNALS-26-01793-JC"],"URL":"https:\/\/doi.org\/10.7326\/annals-26-01793-jc","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}